Effect of Intravenous N-acetylcysteine on Plasma Total Homocysteine and Inflammatory Cytokines During High Flux Hemodialysis

Harnett, 1995, Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors, Kidney Int, 47, 884, 10.1038/ki.1995.132 Stenvinkel, 2002, Inflammation in end-stage renal disease: sources, consequences and therapy, Semin Dial, 15, 330, 10.1046/j.1525-139X.2002.00083.x Kennedy, 2001, Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?, Am J Med, 110, 198, 10.1016/S0002-9343(00)00695-1 Kalantar-Zadeh, 2003, Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences, Am J Kidney Dis, 42, 864, 10.1016/j.ajkd.2003.07.016 Arici, 2001, End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?, Kidney Int, 59, 407, 10.1046/j.1523-1755.2001.059002407.x Stenvinkel, 2005, IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly, Kidney Int, 67, 1216, 10.1111/j.1523-1755.2005.00200.x Rubin, 2007, Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?, Curr Opin Nephrol Hypertens, 16, 506, 10.1097/MNH.0b013e3282f0b331 Hsu, 2004, N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats, J Biomed Sci, 11, 152, 10.1007/BF02256558 Hsu, 2006, Post-treatment with N-acetylcysteine ameliorates the endotoxin shockinduced organ damage in conscious rats, Life Sci, 79, 2010, 10.1016/j.lfs.2006.06.040 Ventura, 1999, N-acetylcysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion, Pharmacol Res, 40, 345, 10.1006/phrs.1999.0519 Wang, 2008, Intravenous N-acetylcysteine improves renal function and ameliorates plasma total homocysteine in patients undergoing cardiac angiography, Ren Fail, 30, 527, 10.1080/08860220802064754 Thaha, 2006, Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease, Clin Drug Investig, 26, 195, 10.2165/00044011-200626040-00003 Scholze, 2004, Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure, Circulation, 109, 369, 10.1161/01.CIR.0000109492.65802.AD Lee, 2008, Fasting serum total ghrelin level inversely correlates with metabolic syndrome in hemodialysis patients, Arch Med Res, 39, 785, 10.1016/j.arcmed.2008.08.005 Himmelfarb, 2002, The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia, Kidney Int, 62, 1524, 10.1046/j.1523-1755.2002.00600.x Himmelfarb, 2003, Oxidative stress in uremia, Curr Opin Nephrol Hypertens, 12, 593, 10.1097/00041552-200311000-00004 Witko-Sarsat, 2003, AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients, Kidney Int, 64, 82, 10.1046/j.1523-1755.2003.00044.x Perna, 2004, Hyperhomocysteinemia and cardiovascular disease in uremia: the newest evidence in epidemiology and mechanisms of action, Semin Nephrol, 24, 426, 10.1016/j.semnephrol.2004.06.019 Mallamaci, 2002, Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients, Kidney Int, 61, 609, 10.1046/j.1523-1755.2002.00144.x Ducloux, 2006, Impact of malnutrition-inflammation on the association between homocysteine and mortality, Kidney Int, 69, 331, 10.1038/sj.ki.5000096 Jamison, 2007, Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial, JAMA, 298, 1163, 10.1001/jama.298.10.1163 Perna, 2008, Is homocysteine toxic in uremia?, J Ren Nutr, 18, 12, 10.1053/j.jrn.2007.10.005 Friedman, 2003, The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study, Am J Kidney Dis, 41, 442, 10.1053/ajkd.2003.50054 Ventura, 2003, Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy, Pharmacology, 68, 105, 10.1159/000069535 De Vriese, 2003, Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients, Nephrol Dial Transplant, 18, 2596, 10.1093/ndt/gfg437